Ursodiol

Post Date:
Jan 24,2013
Expiry Date:
Jul 23,2013
Detailed Description:
Cas No. :128-13-2 Specs:EP6/7, BP, USP, JP
The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery.It is the only FDA approved drug to treat primary biliary cirrhosis.

It is the only FDA approved drug to treat primary biliary cirrhosis.
CAS Registry Number:
128-13-2
Synonyms:
;3,7-Dihydroxycholan-24-oic acid;3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid;Ursodiol;2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethanol;(3alpha,5beta,7alpha)-3,7-dihydroxycholan-24-oic acid;(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid;(4R)-4-[(3R,5S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid;(4R)-4-[(3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid;(3alpha,5beta,7beta,8xi,9xi,14xi)-3,7-dihydroxycholan-24-oic acid;(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oate;(3alpha,5alpha,7beta)-3,7-dihydroxycholan-24-oate;
Molecular Formula:
C₂₄H₃₉O₄
Molecular Weight:
391.5646
Molecular Structure:
Safety Description:
S24/25:;

Offter to Sell